Trial intelligence / Profile preview

Synera Patch Depth and Duration of Anesthesia

NCT00891163Phase 4Completed

Sponsor
ZARS Pharmaceuticals
Start
Dec 2006
Primary completion
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in pain comparing Synera with Placebo (2 arms). Primary endpoints: Sensory and pain depth measurements and Duration of anesthesia provided by the Synera topical patch. Started Dec 2006; status: completed.

02

Drugs

tetracaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT00891163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00891163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call